Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model


PURPOSE The clinical efficacy of cancer peptide vaccine therapy is insufficient. To enhance the anti-tumor effect of peptide vaccine therapy, we combined this therapy with an anti-CD4 mAb (GK1.5), which is known to deplete CD4+ cells, including regulatory T cells (Tregs). METHODS To determine the treatment schedule, the number of lymphocyte subsets in the… (More)
DOI: 10.1016/j.bbrep.2016.02.010

5 Figures and Tables


  • Presentations referencing similar topics